rss
Br J Ophthalmol 2001;85:766 doi:10.1136/bjo.85.7.766
  • Editorial

HAART, CMV retinitis, and monitoring

  1. MARC D DE SMET
  1. Department of Ophthalmology, University of Amsterdam Academic Medical Center, Amsterdam, Netherlands

      With the advent of highly active antiretroviral therapy (HAART), the care of AIDS patients has drastically changed. Patients achieve partial immune reconstitution, appear capable of coming off medication and in many cases do not seem to have recurrences of cytomegalovirus (CMV).12 However, a risk period remains for the first few months after initiating HAART.3 The length of this period remains debatable, as does the best approach to monitor patients …

      [Full text of this article]

      This Article

      1. Extract
      2. Full text
      3. PDF

      Responses

      1. Submit a response
      2. No responses published

      Social bookmarking

      Register for free content


      Free sample
       This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
      View free sample issue >>

      Free archive
      The full back archive is now available for BJO. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
      Register to access the free archive >>

      Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.